Business Context and Reporting Period
This Form 8-K is filed by DORCHESTER MINERALS, L.P. (DMLP) for the reporting period ending October 30, 2025. The filing addresses a significant corporate governance event involving the passing of C.W. ("Bill") Russell, a long-serving manager of the General Partner and member of the Advisory Committee since May 2004.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statement data.
Material Changes
- Advisory Committee Composition: Following Mr. Russell's passing, the Advisory Committee (which also serves as the audit committee) was reduced from three to two members.
- NASDAQ Compliance Status: The reduction in committee members resulted in non-compliance with NASDAQ Listing Rules 5615(a)(4)(C) and 5605(c)(2)(A), which mandate a minimum of three independent audit committee members.
- Regulatory Notification: The Partnership notified NASDAQ of the non-compliance on November 3, 2025, and received an acknowledgment letter on November 10, 2025.
Guidance, Outlook, and Risks
Cure Period and Outlook: NASDAQ has granted the Partnership a cure period to regain compliance. The deadline is the earlier of the next annual unitholders' meeting or October 30, 2026. If the next annual meeting occurs before April 28, 2026, compliance must be evidenced by April 28, 2026.
Management Intent: The Partnership and the General Partner intend to appoint a replacement for the Advisory Committee position that satisfies NASDAQ requirements prior to the expiration of the cure period.
Risks: The primary risk identified is the potential failure to appoint a qualified replacement within the cure period, which could lead to delisting or further regulatory action.
Investor Verification Checklist
- Verify the date of the next annual unitholders' meeting to determine the exact compliance deadline.
- Monitor future filings for the appointment of a new Advisory Committee member.
- Confirm that the new appointee meets the independence requirements of NASDAQ Listing Rules.
- Review the company's governance structure to ensure no other committee requirements are impacted by the vacancy.